Cancer Segment Likely First Market For Roche’s SynergysDx Program
Roche Diagnostics is anticipating that the drive to commercialize pharmacogenomic technology will create a need for coordinated drug and diagnostic premarket efforts, triggering increased demand for development partnerships between the two sectors
More from Archive
More from Medtech Insight
Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.
MedTech Europe is ready to become involved and shape Europe’s Life Sciences Strategy and help drive regulatory simplification from the top to make the EU “the world’s most attractive place for life sciences by 2030.”
The UK government’s blueprint to deliver an NHS "fit for the future" was released on July 3.